New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Recent launches include Stryker’s next-generation Trevo ProVue clot removal device and CooperSurgical’s Carter-Thomason II port closure system for laparoscopic procedures.
You may also be interested in...
Reimbursement In Brief
CMS’ 2014 draft hospital outpatient prospective payment system proposes cuts to CT and MRI and increases for radiation therapy. OIG recommends New York Medicaid set competitive bidding program for test strips. More reimbursement news.
Stryker Buys Concentric Medical To Enter Acute Ischemic Stroke Market
Stryker will gain access to the acute ischemic stroke market by acquiring privately held Concentric Medical for $135 million under a definitive agreement announced Aug. 31.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.